These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29310487)

  • 21. Animal number justification. Stronger rationales encouraged.
    Hart MW; Duktig J
    Lab Anim (NY); 2008 May; 37(5):193-4. PubMed ID: 18431387
    [No Abstract]   [Full Text] [Related]  

  • 22. Sample size planning for the noninferiority or equivalence of a linear contrast with cost considerations.
    Luh WM; Guo JH
    Psychol Methods; 2016 Mar; 21(1):13-34. PubMed ID: 26121080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANIMAL WELFARE FROM MOUSE TO MOOSE--IMPLEMENTING THE PRINCIPLES OF THE 3RS IN WILDLIFE RESEARCH.
    Lindsjö J; Fahlman Å; Törnqvist E
    J Wildl Dis; 2016 Apr; 52(2 Suppl):S65-77. PubMed ID: 26845301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication and the 3Rs: a word from USDA.
    Gipson C
    Lab Anim (NY); 2008 Jan; 37(1):14. PubMed ID: 18094693
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power and sample size for survival analysis under the Weibull distribution when the whole lifespan is of interest.
    Heo M; Faith MS; Allison DB
    Mech Ageing Dev; 1998 May; 102(1):45-53. PubMed ID: 9663791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How many do I need? Basic principles of sample size estimation.
    Devane D; Begley CM; Clarke M
    J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conducting power analyses for ANOVA and ANCOVA in between-subjects designs.
    Algina J; Olejnik S
    Eval Health Prof; 2003 Sep; 26(3):288-314. PubMed ID: 12971201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of endpoint variability and implications for study statistical power and sample size in conscious instrumented dogs.
    Chiang AY; Guth BD; Pugsley MK; Foley CM; Doyle JM; Engwall MJ; Koerner JE; Parish ST; Dustan Sarazan R
    J Pharmacol Toxicol Methods; 2018; 92():43-51. PubMed ID: 29505899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample Power and ExpDesign: tools for improving design of animal experiments.
    van Wilgenburg H; van Schaick Zillesen PG; Krulichova I
    Lab Anim (NY); 2003 Mar; 32(3):39-43. PubMed ID: 12601388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focus on Data: Statistical Design of Experiments and Sample Size Selection Using Power Analysis.
    Ledolter J; Kardon RH
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):11. PubMed ID: 32645134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide.
    de Bekker-Grob EW; Donkers B; Jonker MF; Stolk EA
    Patient; 2015 Oct; 8(5):373-84. PubMed ID: 25726010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication and the 3Rs: an interesting dialog.
    Gracely EJ
    Lab Anim (NY); 2008 Jan; 37(1):13-4. PubMed ID: 18094691
    [No Abstract]   [Full Text] [Related]  

  • 35. Alpha values as a function of sample size, effect size, and power: accuracy over inference.
    Bradley MT; Brand A
    Psychol Rep; 2013 Jun; 112(3):835-44. PubMed ID: 24245076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A myriad of methods: calculated sample size for two proportions was dependent on the choice of sample size formula and software.
    Bell ML; Teixeira-Pinto A; McKenzie JE; Olivier J
    J Clin Epidemiol; 2014 May; 67(5):601-5. PubMed ID: 24439070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical power analysis for growth curve models using SAS.
    Zhang Z; Wang L
    Behav Res Methods; 2009 Nov; 41(4):1083-94. PubMed ID: 19897816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample-Size Planning for More Accurate Statistical Power: A Method Adjusting Sample Effect Sizes for Publication Bias and Uncertainty.
    Anderson SF; Kelley K; Maxwell SE
    Psychol Sci; 2017 Nov; 28(11):1547-1562. PubMed ID: 28902575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.